BSECompany UpdateMgmt Change1d ago
Trigyn Technologies Ltd
Please find attached herewith the disclosure regarding the Appointment of Mr. Narendra Bhandari as an Independent Director subject to the approval of shareholders of the company for the ....
Trigyn Technologies Ltd has announced the appointment of Mr. Narendra Bhandari as an Independent Director, subject to shareholder approval, and has also approved its unaudited financial results for the quarter ended June 30, 2026.
BSECompany UpdateResults1d ago
Trigyn Technologies Ltd
Please find attached herewith Press Release announcement under Regulation 30 for the Quarter Ended June 30, 2027
Trigyn Technologies Ltd has announced its quarterly results for the period ended June 30, 2026, with a consolidated revenue of Rs. 25,275.74 Lakhs and a consolidated profit after tax of Rs. 348.75 Lakhs. The company has also reported a standalone revenue of Rs. 3,799.38 Lakhs and a standalone loss after tax of Rs. 247.98 Lakhs.
BSEResultResults1d ago
Trigyn Technologies Ltd
Please find attached herewith Unaudited Consolidated and Standalone Financial Results for Quarter Ended June 2026
Trigyn Technologies Ltd has announced its unaudited consolidated and standalone financial results for the quarter ended June 2026. The company has also approved the appointment of Mr. Narendra Bhandari as an Independent Director, subject to the approval of the members.
BSEBoard MeetingResults1d ago
Trigyn Technologies Ltd
Outcome of Board Meeting
Trigyn Technologies Ltd announced the outcome of its board meeting, where it approved the unaudited financial results for the quarter ended June 30, 2026, and appointed Mr. Narendra Bhandari as an Independent Director, subject to approval of the members.
BSEBoard MeetingResults4 Aug 2026
Trigyn Technologies Ltd
Trigyn Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Unaudited (Standalone and ....
Trigyn Technologies Ltd has scheduled a board meeting on August 11, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.